Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. September 2025 04:45 ET | Quelle: Novo Nordisk A/S

Novo Nordisk A/S: Ozempic® reduces the risk of heart attack, stroke and death by 23% compared to dulaglutide in the first head-to-head real-world study

Ozempic® (once-weekly injectable semaglutide) was associated with a 23% reduced risk of heart attack, stroke and death in people with type 2 diabetes and cardiovascular disease on Medicare versus...
17. September 2025 17:05 ET | Quelle: Novo Nordisk A/S

Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study participants losing 20% or more body weight1**Oral semaglutide 25 mg also...
17. September 2025 14:34 ET | Quelle: AE2S

AE2S Announces New Office in Boise

Boise, Idaho, Sept. 17, 2025 (GLOBE NEWSWIRE) -- AE2S announces the opening of the civil and environmental consulting engineering firm’s first office in the State of Idaho. The new AE2S office is...
17. September 2025 07:10 ET | Quelle: Research and Markets

South Africa Kitchenware Market Analysis Report 2025-2033, with Profiles of Le Creuset, Newell Brands, Groupe SEB, Meyer, Tramontina, The Vollrath Company, Lifetime Brands, Cuisinart, and OXO

Dublin, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The "South Africa Kitchenware Market Size, Share & Trends Analysis Report By Product (Cookware, Bakeware, Tableware), By Application (Residential,...
16. September 2025 06:00 ET | Quelle: Novo Nordisk A/S

Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme

Positive results show that the average weight loss was 12.5 kg (11.8% body weight reduction) with cagrilintide compared to 2.5 kg (2.3%) with placebo, after 68 weeks*1,2Cagrilintide was...
15. September 2025 18:03 ET | Quelle: Novo Nordisk A/S

People taking Novo Nordisk’s Wegovy® experienced reduced food noise and boosted mental well-being

Results from a real-world survey suggest that semaglutide for weight management (Wegovy®) helped suppress food noise – unwanted and intrusive thoughts about food – in addition to its established...
15. September 2025 08:00 ET | Quelle: Novo Nordisk A/S

EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke

Oral semaglutide (Rybelsus®) is now the first and only oral GLP-1 RA approved for type 2 diabetes, with proven cardiovascular benefits1This approval is based on results from the SOUL clinical trial,...
12. September 2025 10:21 ET | Quelle: Yacht Club de Monaco

Monaco: Sailing and Gastronomy at the Yacht Club during Classic Week with the Chef Competition

MONACO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- At the Monaco Classic Week, running until September 13, the spectacle isn’t confined to the sea. While regattas unfold on the waters of the Principality -...
10. September 2025 01:00 ET | Quelle: Novo Nordisk A/S

Novo Nordisk to streamline operations and reinvest for growth

Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patientsIntention to reduce ~9,000 roles globally...
09. September 2025 09:00 ET | Quelle: Premier Truck Rental

Executive Team Expansion: PTR Welcomes Jamie Meyer as Chief Operating Officer

Fort Wayne, IN, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Premier Truck Rental (PTR), a nationwide custom work truck and trailer rental provider, is pleased to announce that Jamie Meyer has joined the...

Vorherige Seite

Nächste Seite